Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014 Stephan von HaehlingStefan D. Anker Editorial 11 November 2014 Pages: 261 - 263
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology—update 2014 John E. MorleyStefan D. AnkerStephan von Haehling Editorial 22 October 2014 Pages: 253 - 259
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile Claudio PietraYasuhiro TakedaRobert Northrup Original Article 30 September 2014 Pages: 329 - 337
Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management Hidetaka WakabayashiKunihiro Sakuma Review 16 September 2014 Pages: 269 - 277
Erratum to: Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure Tuba KhawajaAalap ChokshiP. Christian Schulze Erratum 11 September 2014 Pages: 349 - 349
Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention Stefan D. AnkerStephan von Haehling Editorial 06 September 2014 Pages: 171 - 176
Formoterol in the treatment of experimental cancer cachexia: effects on heart function Míriam ToledoJochen SpringerJosep M. Argilés Original Article 29 August 2014 Pages: 315 - 320
Muscle wasting: an overview of recent developments in basic research Sandra PalusStephan von HaehlingJochen Springer Review 28 August 2014 Pages: 193 - 198
Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients? Connie M. RheeKamyar Kalantar-Zadeh Editorial 28 August 2014 Pages: 177 - 180
Cachexia: a problem of energetic inefficiency Josep M. ArgilésCibely Cristine Fontes-OliveiraSílvia Busquets Review 15 August 2014 Pages: 279 - 286
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure Tuba KhawajaAalap ChokshiChristian P. Schulze Original Article 07 August 2014 Pages: 297 - 305
Sarcopenia: describing rather than defining a condition David Rhys Alchin Review 05 August 2014 Pages: 265 - 268
Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones Krystian JosiakEwa A. JankowskaPiotr Ponikowski Review 01 August 2014 Pages: 287 - 296
An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada Denis GuttridgeMarion CouchTeresa Zimmers Editorial 26 June 2014 Pages: 181 - 181
Left ventricular mass correlates with lean body mass in patients with disease-associated wasting Alessio MolfinoAlessia PapaAlessandro Laviano Letter to the Editor 05 June 2014 Pages: 251 - 252
Relationship between arterial stiffening and skeletal muscle atrophy in hemodialysis patients: a gender comparative study Akihiko KatoTakako TakitaHiromichi Kumagai Letter to the Editor 05 June 2014 Pages: 247 - 249
Erratum to: Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility Timothy R. HenwoodJustin W. KeoghHugh E. Senior Erratum 05 June 2014 Pages: 237 - 237
Synemin: an evolving role in tumor growth and progression Shailendra Kapoor Letter to the Editor 28 May 2014 Pages: 347 - 348
Are we closer to having drugs to treat muscle wasting disease? John E. MorleyStephan von HaehlingStefan D. Anker Editorial 28 May 2014 Pages: 83 - 87
Daily physical activity and physical function in adult maintenance hemodialysis patients J. C. KimB. B. ShapiroJ. D. Kopple Original Article 29 April 2014 Pages: 209 - 220
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer? David R. FogelmanHolly HolmesMilind Javle Original Article 17 April 2014 Pages: 307 - 313
Osteosarcopenic obesity: the role of bone, muscle, and fat on health Michael J. OrmsbeeCarla M. PradoLynn Panton Review 17 April 2014 Pages: 183 - 192
Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility Timothy R. HenwoodJustin W. KeoghHugh E. Senior Original Article 16 April 2014 Pages: 229 - 236
Identifying recreational physical activities associated with muscle quality in men and women aged 50 years and over Sébastien Barbat-ArtigasSophie DupontgandMylène Aubertin-Leheudre Original Article 16 April 2014 Pages: 221 - 228
Anabolic exercise in haemodialysis patients: a randomised controlled pilot study Danielle L. KirkmanPaul MullinsJamie H. Macdonald Original Article 08 April 2014 Pages: 199 - 207
An overview of amines as nutritional supplements to counteract cancer cachexia Patrícia Lopes de Campos-FerrazIsabel AndradeAntonio Herbert Lancha Jr Review 28 March 2014 Pages: 105 - 110
Modeling human cancer cachexia in colon 26 tumor-bearing adult mice Erin E. TalbertGregory A. MetzgerDenis C. Guttridge Original Article 26 March 2014 Pages: 321 - 328
Attenuation of muscle wasting in murine C2C12 myotubes by epigallocatechin-3-gallate Kamran A. MirzaSuzette L. PereiraMichael J. Tisdale Original Article 20 March 2014 Pages: 339 - 345
Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist Seyyed M. R. Kazemi-BajestaniHarald BecherVickie E. Baracos Review 14 March 2014 Pages: 95 - 104
Patients’ rationale for declining participation in a cancer-associated weight loss study Tammy WangerNathan R. FosterAminah Jatoi Original Article 13 March 2014 Pages: 121 - 125
1-Sarcosine–angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model S. A. CichelloR. S. WeisingerM. Jois Original Article 11 March 2014 Pages: 239 - 246
Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies Nicole EbnerLisa SteinbeckStephan von Haehling Meeting Report 05 March 2014 Pages: 27 - 34
Muscle wasting disease: a proposal for a new disease classification Stefan D. AnkerAndrew J. S. CoatsKamyar Kalantar-Zadeh Editorial 05 March 2014 Pages: 1 - 3
Assessing skeletal muscle mass: historical overview and state of the art Steven B. HeymsfieldMichael AdamekDiana M. Thomas Review 15 February 2014 Pages: 9 - 18
From sarcopenia to frailty: a road less traveled John E. MorleyStephan von HaehlingBruno Vellas Editorial 14 February 2014 Pages: 5 - 8
Reductions in C-reactive protein in older adults with type 2 diabetes are related to improvements in body composition following a randomized controlled trial of resistance training Yorgi MavrosShelley KayMaria A. Fiatarone Singh Original Article 12 February 2014 Pages: 111 - 120
Abstracts of the 7th Cachexia Conference, Kobe/Osaka, Japan, December 9–11, 2013 (Part 2) Events 08 February 2014 Pages: 35 - 78
Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer Céline M. H. Op den KampDirk K. M. De RuysscherAnne-Marie C. Dingemans Original Article 23 January 2014 Pages: 127 - 137
Availability and use of dual energy X-ray absorptiometry (DXA) and bio-impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin American geriatricians Everardo Treviño-AguirreTeresa López-TerosMario Pérez-Zepeda Letter to the Editor 18 January 2014 Pages: 79 - 81
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats Mareike S. PötschAnika TschirnerJochen Springer Original Article 22 November 2013 Pages: 149 - 158
Hypothalamic food intake regulation in a cancer-cachectic mouse model Jvalini T. DwarkasingMiriam van DijkKlaske van Norren Original Article 13 November 2013 Pages: 159 - 169
Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults Maren S. FragalaAdam R. JajtnerJeffrey R. Stout Original Article 07 November 2013 Pages: 139 - 148
Cachexia vs obesity: where is the real unmet clinical need? Stephan von HaehlingStefan D. Anker Editorial 07 November 2013 Pages: 245 - 246
Abstracts of the 7th Cachexia Conference, Kobe/Osaka, Japan, December 9–11, 2013 Events 05 November 2013 Pages: 295 - 343
Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial Manoch RattanasompattikulMiklos Z. MolnarKamyar Kalantar-Zadeh Original Article 20 September 2013 Pages: 247 - 257
Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice E. C. A. HinchM. J. Sullivan-GunnPaul A. Lewandowski Original Article 13 September 2013 Pages: 287 - 293
Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss M. Sheffield-MooreE. L. DillonW. J. Durham Original Article 06 September 2013 Pages: 19 - 25
An invitation to the 7th Cachexia Conference, Kobe, Japan Akio Inui Editorial 04 September 2013 Pages: 171 - 171
Type VI collagen turnover-related peptides—novel serological biomarkers of muscle mass and anabolic response to loading in young men Anders NedergaardShu SunCharlotte Suetta Original Article 13 August 2013 Pages: 267 - 275
